FDA Inspection 1266979 — OneBlood Inc.
The FDA completed an inspection of OneBlood Inc. on March 13, 2025 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Greenville, SC (United States)